Akèy › Psoryaz
Etid klinik pou Psoryaz ap rekrite nan Etazini
39 etid pou Psoryaz ap rekrite patisipan nan sit atravè Etazini.
Vil ki gen plis etid
- Trenton, NJ7 etid
- Newton, MA6 etid
- Cleveland, OH6 etid
- New York City, NY5 etid
- San Antonio, TX5 etid
- Fremont, CA5 etid
- Philadelphia, PA5 etid
- Miami, FL4 etid
- Huntington Beach, CA4 etid
- Birmingham, AL4 etid
- Rochester, NY3 etid
- Houston, TX3 etid
- Indianapolis, IN3 etid
- San Diego, CA3 etid
- Sacramento, CA3 etid
- Hialeah, FL3 etid
- Los Angeles, CA3 etid
- Tampa, FL3 etid
- Columbus, OH3 etid
- Dallas, TX3 etid
Pa eta
- Alabama4 etid
- Arizona3 etid
- Florid8 etid
- Georgia4 etid
- Indiana4 etid
- Kalifòni14 etid
- Kentucky4 etid
- Maryland4 etid
- Massachusetts9 etid
- Michigan4 etid
- New Jersey9 etid
- New York8 etid
- North Carolina3 etid
- Ohio9 etid
- Pennsylvania6 etid
- Texas8 etid
- Washington3 etid
Etid ki fèk mete ajou
Tèks ofisyèl etid la (Anglè)
A 16-week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream 20 mg/g in Adult Participants With Mild to Severe Palmoplantar Pustulosis
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07013201A Study to Assess Deucravacitinib Safety in Pregnancy
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Tout laj · Fanm · Mizajou Oct 1, 2026 · NCT07017699A Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Moderate to Severe Psoriatic Arthritis
Ap rekriteFaz 2
Laj 18 a 100 · Tout sèks · Mizajou Sep 25, 2026 · NCT07801495Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
Ap rekriteFaz 1
Laj 18 ak plis · Tout sèks · Mizajou Sep 23, 2026 · NCT03816345Open Label Study to Investigate the Safety and Efficacy of Ponesimod in Moderate-to-Severe Chronic Plaque Psoriasis
Ap rekriteFaz 3
Laj 18 a 65 · Tout sèks · Mizajou Sep 22, 2026 · NCT07362017Metabolic Profiling of Immune Responses in Immune-mediated Diseases
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 a 75 · Tout sèks · Mizajou Sep 22, 2026 · NCT04864886The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin Disease
Ap rekriteFaz 4Volontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 9, 2026 · NCT07487831Mediterranean Diet vs no Dietary Intervention for Improving Signs and Symptoms of Psoriasis in Patients Treated With Anti-IL-17 or Anti-IL-23 Inhibitors
Ap rekrite
Laj 18 a 94 · Tout sèks · Mizajou Sep 4, 2026 · NCT06399432A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Sep 4, 2026 · NCT06857942A Study to Evaluate the Efficacy, Safety, and Drug Levels of Deucravacitinib (BMS-986165) in Adolescent Participants With Moderate to Severe Plaque Psoriasis
Ap rekriteFaz 3
Laj 12 a 17 · Tout sèks · Mizajou Sep 3, 2026 · NCT06979453A Study to Assess Concentration of TREMFYA in Breast Milk of Lactating Women Who Are Receiving TREMFYA Therapeutically
Ap rekriteFaz 4
Laj 18 ak plis · Fanm · Mizajou Aug 28, 2026 · NCT07654751The CorEvitas Psoriasis (PSO) Registry
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Aug 27, 2026 · NCT02707341A Study to Evaluate the Efficacy and Safety of Bimekizumab in Study Participants With Palmoplantar Pustulosis
Ap rekriteFaz 3
Laj 18 ak plis · Tout sèks · Mizajou Aug 27, 2026 · NCT07219420PPD™ CorEvitas™ Psoriasis (PSO) Rapid Response Non-Interventional Study
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Aug 26, 2026 · NCT07615712CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness Registry
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Aug 26, 2026 · NCT06100991PPD™ CorEvitas™ Psoriasis (PSO) Early Treatment Response Non-Interventional Study
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Aug 26, 2026 · NCT07648602The Effects of Audio-Based Therapy on Anxiety in Psoriasis
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jul 23, 2026 · NCT07390487Skin Microbial Ecology in Atopic Dermatitis
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 13 ak plis · Tout sèks · Mizajou Jul 14, 2026 · NCT04170244A Study to Evaluate D-2570 in Participants With Moderate to Severe Plaque Psoriasis
Ap rekriteFaz 2
Laj 18 a 70 · Tout sèks · Mizajou Jul 9, 2026 · NCT07489885Use of Total-Body PET to Quantify Systemic and Cutaneous Inflammation in Psoriasis Patients Before and After Intervention With a Nutritionally Balanced Diet
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Jun 16, 2026 · NCT06574178Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou May 20, 2026 · NCT04751396Regulation of Inflammatory Genes in Psoriasis
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 19 a 99 · Tout sèks · Mizajou Apr 6, 2026 · NCT03125655Development of Predictive Psoriasis Response Endotypes Using Single Cell Transcriptomics
Ap rekriteFaz 4
Laj 18 a 89 · Tout sèks · Mizajou Apr 2, 2026 · NCT05270733Multi-Center PAMPA Study
Ap rekriteFaz 4
Laj 18 ak plis · Tout sèks · Mizajou Mar 30, 2026 · NCT05004727A Study to Evaluate the Impact of a Magnolia Officinalis Dietary Supplement on Immune Biomarkers in Subjects With Psoriasis
Ap rekrite
Laj 18 ak plis · Tout sèks · Mizajou Mar 13, 2026 · NCT07471048Sous ClinicalTrials.gov, done yo ranmase Oct 2, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.